Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

被引:177
作者
Khanna, R [1 ]
Burrows, SR
机构
[1] Queensland Inst Med Res, Div Infect Dis & Immunol, Tumor Immunol Lab, Brisbane, Qld 4006, Australia
[2] Univ Queensland, Bancroft Ctr, Joint Oncol Program, Brisbane, Qld, Australia
关键词
latency; lymphoma; immumodulation; epitope; immune escape; immunotherapy;
D O I
10.1146/annurev.micro.54.1.19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Adaptation of persistent infection within the cells of the immune system is a unique characteristic of gamma herpes viruses. A classic example of this is Epstein-Barr virus (EBV), which may have co-evolved with Homo sapiens over millions of years, thus achieving a balance between viral persistence and immune control. In this review, we present an overview of virus and the host immune system interactions that regulate the life-long host-virus relationship in healthy virus carriers and EBV-associated diseases. Extensive analysis of cytotoxic T lymphocyte-mediated immune responses in healthy virus carriers has revealed unique mechanisms used by EBV to maintain a benign persistent state in vivo. On the other hand, this relationship in EBV-associated diseases favors the escape of the virus from the hostile effects of the immune response. This escape is achieved by either down-regulating the expression of highly immunogenic antigens of the virus or by direct modulation of the host cytotoxic T lymphocyte response by virus-encoded proteins.
引用
收藏
页码:19 / 48
页数:30
相关论文
共 93 条
[1]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[2]  
[Anonymous], BIOMAT RES
[3]   SEQUENCE VARIATION OF CYTOTOXIC T-CELL EPITOPES IN DIFFERENT ISOLATES OF EPSTEIN-BARR-VIRUS [J].
APOLLONI, A ;
MOSS, D ;
STUMM, R ;
BURROWS, S ;
SUHRBIER, A ;
MISKO, I ;
SCHMIDT, C ;
SCULLEY, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (01) :183-189
[4]   Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses [J].
Bejarano, MT ;
Masucci, MG .
BLOOD, 1998, 92 (11) :4256-4262
[5]   Human CD8+ T cell responses to EBV EBNA1:: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing [J].
Blake, N ;
Lee, S ;
Redchenko, I ;
Thomas, W ;
Steven, N ;
Leese, A ;
Steigerwald-Mullen, P ;
Kurilla, MG ;
Frappier, L ;
Rickinson, A .
IMMUNITY, 1997, 7 (06) :791-802
[6]   SPECIFIC CYTOTOXIC T-LYMPHOCYTES RECOGNIZE THE IMMEDIATE-EARLY TRANSACTIVATOR ZTA OF EPSTEIN-BARR-VIRUS [J].
BOGEDAIN, C ;
WOLF, H ;
MODROW, S ;
STUBER, G ;
JILG, W .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4872-4879
[7]  
BURKITT DP, 1969, JNCI-J NATL CANCER I, V42, P19
[8]   Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: Implications for virus evolution [J].
Burrows, JM ;
Burrows, SR ;
Poulsen, LM ;
Sculley, TB ;
Moss, DJ ;
Khanna, R .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2490-2496
[9]   5 NEW CYTOTOXIC T-CELL EPITOPES IDENTIFIED WITHIN EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-3 [J].
BURROWS, SR ;
GARDNER, J ;
KHANNA, R ;
STEWARD, T ;
MOSS, DJ ;
RODDA, S ;
SUHRBIER, A .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :2489-2493
[10]   AN EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC T-CELL EPITOPE PRESENT ON A-TYPE AND B-TYPE TRANSFORMANTS [J].
BURROWS, SR ;
MISKO, IS ;
SCULLEY, TB ;
SCHMIDT, C ;
MOSS, DJ .
JOURNAL OF VIROLOGY, 1990, 64 (08) :3974-3976